Peter Riedell

30PUBLICATIONS
188CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersLiquid biopsiesGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Jul 28, 2026
Lisocabtagene maraleucel combined with ibrutinib in R/R CLL or SLL: primary results from TRANSCEND CLL 004.

|May 11, 2026
Low-Strength Type I Interferon Signaling Promotes CAR T-cell Treatment Efficacy.

|Apr 26, 2026
Therapeutic targeting of BCL-2 during CART cell production augments potency through non-apoptotic adaptive changes.

|Mar 24, 2026
Prognosis and treatment of plasmablastic lymphoma in the United States: a multicenter retrospective study.

Matthew Hamby, Brian L Egleston, Zachary A K Frosch

|Nov 19, 2025
Prognosis and Treatment of Plasmablastic Lymphoma in the United States: A Multicenter Retrospective Study.

Matthew Hamby, Brian Egleston, Zachary Frosch

|Aug 14, 2025
New comorbidity index associated with survival after chimeric antigen receptor T-cell therapy for large B-cell lymphoma.

Uri Greenbaum, Hamza Hashmi, Mahmoud Elsawy

Pageof 5

Frequent Collaborators

9 joint publications

Joseph P McGurik

6 joint publications

Miguel-Angel Perales

6 joint publications

Loretta J Nastoupil

5 joint publications

Mehdi Hamadani